Literature DB >> 3754662

Acute toxicity of nimbolide and nimbic acid in mice, rats and hamsters.

T Glinsukon, R Somjaree, P Piyachaturawat, Y Thebtaranonth.   

Abstract

Nimbolide and nimbic acid are toxic to mice only when given i.p. and i.v. but they are less toxic to rats and hamsters. The LD50 values of a single i.p. administration of nimbolide to adult male, female and weanling mice were 225, 280 and 240 mg/kg body wt, respectively, and its i.v. LD50 value was decreased to 24 mg/kg body wt in adult male mice. No fatality was observed when nimbolide was given i.g., i.m. and s.c. to adult male mice. Estimated LD50 values of nimbolide in rats and hamsters were somewhat higher than 600 and 500 mg/kg body wt. After 12-23 h i.p. administration of a lethal dose, most animals died of possible dysfunctions in kidney (tubular necrosis), small intestine (hemorrhagic necrosis), pancreas (acinar cell necrosis) and liver (mild fatty infiltration and focal necrosis). In contrast, mice and rats given a lethal dose of nimbolide (i.v.) died of a marked and sudden drop in arterial blood pressure and respiratory paralysis within about 1-18 min. Nimbic acid was less toxic to mice with an i.v. LD50 value of 265 mg/kg body wt and i.p. and i.g. LD50 values of higher than 600 mg/kg body wt. The possible cause of death induced by nimbic acid may be similar to that of nimbolide given i.v. and this is a sudden hypotensive shock.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754662     DOI: 10.1016/0378-4274(86)90098-6

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia.

Authors:  K Chitta; A Paulus; T R Caulfield; S Akhtar; M-K K Blake; S Ailawadhi; J Knight; M G Heckman; A Pinkerton; A Chanan-Khan
Journal:  Blood Cancer J       Date:  2014-11-07       Impact factor: 11.037

2.  Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation.

Authors:  Venkatesh Pooladanda; Sowjanya Thatikonda; Swarna Bale; Bijay Pattnaik; Dilep Kumar Sigalapalli; Nagendra Babu Bathini; Shashi Bala Singh; Chandraiah Godugu
Journal:  Cell Death Dis       Date:  2019-01-28       Impact factor: 8.469

Review 3.  Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review.

Authors:  Neelu Batra; Vigneshwari Easwar Kumar; Roshni Nambiar; Cristabelle De Souza; Ashley Yuen; Uyen Le; Rashmi Verma; Paramita M Ghosh; Ruth L Vinall
Journal:  Ann Transl Med       Date:  2022-07

Review 4.  Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development.

Authors:  Lingzhi Wang; Do Dang Khoa Phan; Jingwen Zhang; Pei-Shi Ong; Win Lwin Thuya; Ross Soo; Andrea Li-Ann Wong; Wei Peng Yong; Soo Chin Lee; Paul Chi-Lui Ho; Gautam Sethi; Boon Cher Goh
Journal:  Oncotarget       Date:  2016-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.